@bruces One of the major problems here is the American left is consistently misidentifying the problems here.

The continued focus on things like M4A (whereas most of the countries doing much better here don't have single payer systems), allows the GOP and the pharma lobby to distract the situation and prevents the US from addressing the real problems.

Some of those real issues are very questionable patent laws about pharma and excessive diagnostic procedures. Not a lack of M4A.